Product Information
A human-derived monoclonal antibody binding preferentially to aggregated forms of extracellular α-synuclein for the treatment of early Parkinson's disease.
Chemical properties
Technical inquiry about: 3D-CLA1575 Cinpanemab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.